PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease

We analysed relationships between the PTPN22 1858 polymorphism and antibodies to cyclic citrullinated peptide (CCP), rheumatoid factors (RFs) and the shared epitope (SE) gene (HLA-DRB1*0404 or 0401) and determined their combined predictive value for rheumatoid arthritis (RA) in individuals who subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Martin, Ärlestig, Lisbeth, Hallmans, Göran, Rantapää-Dahlqvist, Solbritt
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526580/
https://www.ncbi.nlm.nih.gov/pubmed/16507117
http://dx.doi.org/10.1186/ar1868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526580/
https://www.ncbi.nlm.nih.gov/pubmed/16507117
http://dx.doi.org/10.1186/ar1868

Ejemplares similares